PATENT CLAIM ANALYSIS

Application Number: 15917973
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["546", "089000"]

Abstract:
The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof. For Formula I compounds X, Y, R 1 , R 2 , R 3a , R 3b , R 4a , R 4b  and R 5  are as defined in the specification. The inventive Formula I compounds are inhibitors of eIF4A and find utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers.

Claim (Index 9):
The method according to  claim 1  wherein R 4b  is OH.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.62712
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15358761', '14772731', '15676726', '15108391', '10420390']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7603084725985718
- 35 USC 102 Novelty (BERT): 0.6992697684764895
- Combined Prediction Score: 0.7542046021863635
- Mean Citation Score: 432.51935
- Max Citation Score: 864.5835599999997
- Similarity Product: 690.0658765073633

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test